Phytobioactive compounds as therapeutic agents for human diseases: A review.
Muhammad RiazRamsha KhalidMuhammad AfzalFozia AnjumHina FatimaSaadiya ZiaGhulam RasoolChukwuebuka EgbunaAndrew G MtewaChukwuemelie Zedech UcheMuhammad Aamir AslamPublished in: Food science & nutrition (2023)
Phytobioactive compounds are plant secondary metabolites and bioactive compounds abundantly present in medicinal plants and have remarkable therapeutic potential. Oxidative stress and antibiotic resistance are major causes of present-day ailments such as diabetes, atherosclerosis, cardiovascular disorders, cancer, and inflammation. The data for this review were collected from Google Scholar, PubMed, Directory of Open Access Journals (DOAJ), and Science Direct by using keywords: "Medicinal plants, Phytobioactive compounds, Polyphenols, Alkaloids, Carotenoids etc." Several studies have reported the pharmacological and therapeutic potential of the phytobioactives. Polyphenols, alkaloids, terpenes, and polysaccharides isolated from medicinal plants showed remarkable antioxidant, anticancer, cytotoxic, anti-inflammatory, cardioprotective, hepatoprotective, immunomodulatory, neuroprotective, and antidiabetic activities. This literature review was planned to provide comprehensive insight into the biopharmacological and therapeutic potential of phytobioactive compounds. The techniques used for the extraction and isolation of phytobioactive compounds, and bioassays required for their biological activities such as antioxidant, antimicrobial, anti-inflammatory, and cytotoxic activities, have been discussed. Characterization techniques for the structural elucidation of phytobioactive compounds such as HPLC, TLC, FTIR, GC-MS/MS, and NMR have also been discussed. This review concludes that phytobioactive compounds may be used as potential alternative to synthetic compounds as therapeutic agents for the treatment of various diseases.
Keyphrases
- oxidative stress
- ms ms
- anti inflammatory
- public health
- staphylococcus aureus
- high resolution
- randomized controlled trial
- minimally invasive
- squamous cell carcinoma
- dna damage
- skeletal muscle
- metabolic syndrome
- adipose tissue
- ischemia reperfusion injury
- electronic health record
- endoplasmic reticulum stress
- induced pluripotent stem cells
- heat stress
- childhood cancer